Teva Shares Progress Toward Access to Medicines and Environmental Commitments, Meeting and Exceeding Several ESG Targets Ahead of Schedule
![Teva Launches Two Digital Inhalers in the U.S., AirDuo® Digihaler® (fluticasone propionate and salmeterol) Inhalation Powder and ArmonAir® Digihaler® (fluticasone propionate) Inhalation Powder Teva Launches Two Digital Inhalers in the U.S., AirDuo® Digihaler® (fluticasone propionate and salmeterol) Inhalation Powder and ArmonAir® Digihaler® (fluticasone propionate) Inhalation Powder](https://mms.businesswire.com/media/20200921005170/en/819864/4/Interactive_Media_Placeholder_webready.jpg)
Teva Launches Two Digital Inhalers in the U.S., AirDuo® Digihaler® (fluticasone propionate and salmeterol) Inhalation Powder and ArmonAir® Digihaler® (fluticasone propionate) Inhalation Powder
![Teva Announces Unique Collaboration with HealthSnap to Expand the Reach of its Respiratory Digital Health Platform | Business Wire Teva Announces Unique Collaboration with HealthSnap to Expand the Reach of its Respiratory Digital Health Platform | Business Wire](https://mms.businesswire.com/media/20221114005344/en/739014/23/teva_RGB_JPEG.jpg)
Teva Announces Unique Collaboration with HealthSnap to Expand the Reach of its Respiratory Digital Health Platform | Business Wire
![Teva and Ignyta Announce Acquisition by Ignyta of Four Oncology R&D Assets from Teva | Business Wire Teva and Ignyta Announce Acquisition by Ignyta of Four Oncology R&D Assets from Teva | Business Wire](https://mms.businesswire.com/media/20150317006367/en/457958/4/teva_logo.jpg)